Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely used antihypertensive drug, is an angiotensin II type 1 (AT1) receptor blocker (ARB) that might inhibit cancer cell proliferation, but the mech...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Rep
Main Authors: Oura, Kyoko, Tadokoro, Tomoko, Fujihara, Shintaro, Morishita, Asahiro, Chiyo, Taiga, Samukawa, Eri, Yamana, Yoshimi, Fujita, Koji, Sakamoto, Teppei, Nomura, Takako, Yoneyama, Hirohito, Kobara, Hideki, Mori, Hirohito, Iwama, Hisakazu, Okano, Keiichi, Suzuki, Yasuyuki, Masaki, Tsutomu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5780034/
https://ncbi.nlm.nih.gov/pubmed/29048654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5977
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados